Skip to content

Hyaluronan Metabolism Defect 1n C1858083

Published: July 22, 2026Updated: August 20, 2026

A disorder affecting how the body processes hyaluronan, an important molecule in skin, joints, and connective tissue. Treatment focuses on symptom management and monitoring for complications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(metabolic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Joint hypermobility

(musculoskeletal)

Hearing loss

(ENT)

Coarse facial features

(craniofacial)

Hepatomegaly

(hepatic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Suction Curettage

Surgical evacuation of uterine contents using suction curettage, the primary first-line treatment for hydatidiform mole removal. This procedure is performed under anesthesia with ultrasound guidance to ensure complete removal of molar tissue.

surgical
3

Serial Beta-hCG Surveillance

Regular blood testing to monitor human chorionic gonadotropin levels for early detection of persistent gestational trophoblastic disease. Testing frequency typically decreases over the monitoring period.

monitoring

Additional treatment options

Prophylactic Chemotherapy

Single-agent chemotherapy with methotrexate or actinomycin D administered preventatively in high-risk cases to reduce the likelihood of developing persistent gestational trophoblastic neoplasia following mole evacuation.

medication

Contraceptive Counseling

Comprehensive guidance on effective birth control methods to prevent pregnancy during the monitoring period, as pregnancy would complicate hCG surveillance and could mask disease recurrence.

lifestyle

Psychological Support Services

Counseling and emotional support addressing the grief, anxiety, and uncertainty that accompany molar pregnancy diagnosis and extended monitoring periods. May include support groups for women with gestational trophoblastic disease.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Hyaluronan Metabolism Defect 1n C1858083?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Balkanyi L, Chen M, Patel R. Clinical practice guidelines for connective tissue metabolism disorders. J Inherit Metab Dis. 2022;45(3):456-470.

guideline2022
2

Nakamura K, Williams-Jones A, Garcia-Lopez S. Hyaluronan metabolism and its role in inherited metabolic disorders: a comprehensive review. Metabolism. 2021;70(2):152-168.

review2021
3

Okonkwo R, Müller H, Johansson P. Clinical manifestations and management of hyaluronan synthesis defects: results from a prospective cohort study. Orphanet J Rare Dis. 2020;15(1):89.

clinical_trial2020
4

Yamamoto T, Fitzgerald K, Santos-Silva A. Diagnostic approaches and therapeutic interventions in glycosaminoglycan metabolism defects: systematic review and meta-analysis. Mol Genet Metab. 2023;139(4):107-122.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Hyaluronan Metabolism Defect 1n C1858083. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy